Загрузка...
Increased exposure of norethindrone in HIV+ women treated with ritonavir boosted atazanavir therapy
OBJECTIVE: Pharmacokinetics of norethindrone in combination oral contraceptive regimen are well described among HIV+ women treated with ritonavir boosted protease inhibitor therapies; however such characterization is lacking in women using progestin-only contraception. Our objective is to characteri...
Сохранить в:
| Опубликовано в: : | Contraception |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4268426/ https://ncbi.nlm.nih.gov/pubmed/25245190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.contraception.2014.08.009 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|